Inventor · disambiguated record
Son Minh Pham
Also filed as: PHAM SON M · PHAM SON MINH
34 granted patents·40 pending applications·59 citations·filing 2007–2024
96Inventor score
Top patents by PatentIndex Score
74 records- 0194US11834458B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Dec 5, 2023·2 cites·34 claims
- 0293US12006314B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Jun 11, 2024·2 cites·17 claims
- 0392US11584756B2Heterocyclic compounds as BET inhibitorsNUVATION BIO INC·Filed 2020·Granted Feb 21, 2023·3 cites·31 claims
- 0491US9533970B2Multisubstituted aromatic compounds as serine protease inhibitorsVERSEON CORP·Filed 2014·Granted Jan 3, 2017·5 cites·25 claims
- 0590US11952349B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2020·Granted Apr 9, 2024·2 cites·10 claims
- 0690US11826430B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2020·Granted Nov 28, 2023·2 cites·8 claims
- 0790US11292782B2Diarylhydantoin compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Apr 5, 2022·6 cites·39 claims
- 0890US11034669B2Pyrrole and pyrazole compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0983US10793561B21,8-naphthyridinone compounds and uses thereofNUVATION BIO INC·Filed 2018·Granted Oct 6, 2020·3 cites·76 claims
- 1083US9963440B2Multisubstituted aromatic compounds as inhibitors of thrombinVERSEON CORP·Filed 2016·Granted May 8, 2018·3 cites·30 claims
- 1183US9533967B2Multisubstituted aromatic compounds as inhibitors of thrombinVERSEON CORP·Filed 2012·Granted Jan 3, 2017·5 cites·22 claims
- 1282US10030004B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2014·Granted Jul 24, 2018·6 cites·10 claims
- 1381US10807994B2Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2018·Granted Oct 20, 2020·3 cites·59 claims
- 1481US9687479B2Multisubstituted aromatic compounds as serine protease inhibitorsVERSEON CORP·Filed 2016·Granted Jun 27, 2017·2 cites·29 claims
- 1580US12208141B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2023·Granted Jan 28, 2025·0 cites·19 claims
- 1680US10653674B2Multisubstituted aromatic compounds as inhibitors of thrombinVERSEON CORP·Filed 2018·Granted May 19, 2020·1 cites·49 claims
- 1780US10189810B2Pyrazolyl-substituted pyridone compounds as serine protease inhibitorsVERSEON CORP·Filed 2015·Granted Jan 29, 2019·3 cites·66 claims
- 1879US11028058B2Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2018·Granted Jun 8, 2021·2 cites·52 claims
- 1978US2025276978A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2024·Application pending·0 cites
- 2076US11174252B2Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2019·Granted Nov 16, 2021·1 cites·106 claims
- 2175US11053216B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2019·Granted Jul 6, 2021·0 cites·19 claims
- 2274US2024352027A1Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2023·Application pending·0 cites
- 2373US11702401B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2021·Granted Jul 18, 2023·0 cites·26 claims
- 2473US2023339964A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2023·Application pending·0 cites
- 2573US2019142813A1Multisubstituted aromatic compounds as serine protease inhibitorsVERSEON CORP·Filed 2019·Application pending·0 cites
- 2669US9670172B2Heterocyclic compounds and methods of useMEDIVATION TECHNOLOGIES INC·Filed 2014·Granted Jun 6, 2017·2 cites·36 claims
- 2768US12398121B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Aug 26, 2025·0 cites·12 claims
- 2865US10251872B2Multisubstituted aromatic compounds as serine protease inhibitorsVERSEON CORP·Filed 2017·Granted Apr 9, 2019·0 cites·14 claims
- 2965US2022213122A1Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitorsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 3064US2023118115A1SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINES AS WEE1 INHIBITORSNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 3163US2023109104A1Heterocyclic compounds and uses thereofNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 3262US11192900B2Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitorsNUVATION BIO INC·Filed 2019·Granted Dec 7, 2021·0 cites·25 claims
- 3362US10058541B2Multisubstituted aromatic compounds as serine protease inhibitorsVERSEON CORP·Filed 2017·Granted Aug 28, 2018·0 cites·13 claims
- 3462US2022298142A1Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 3562US2022169648A11,8-naphthyridinone compounds and uses thereofNUVATION BIO INC·Filed 2022·Application pending·0 cites
- 3661US2019375732A1Anti-cancer nuclear hormone receptor-targeting compoundsHUNG DAVID·Filed 2019·Application pending·0 cites
- 3760US11306071B2Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2020·Granted Apr 19, 2022·0 cites·20 claims
- 3860US2023062022A1Heterocyclic compounds as kinase inhibitorsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 3960US2024343710A1Heterocyclic compounds and methods of use thereof1CBIO INC·Filed 2024·Application pending·0 cites
- 4059US2021292285A1Heterocyclic compounds as adenosine antagonistsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 4158US2024132522A1Heterocyclic compounds and methods of use thereof1CBIO INC·Filed 2023·Application pending·0 cites
- 4258US2024132449A1Heterocyclic compounds and methods of use thereof1CBIO INC·Filed 2023·Application pending·0 cites
- 4357US10501436B2Compounds and methods of useMEDIVATION TECH LLC·Filed 2018·Granted Dec 10, 2019·0 cites·21 claims
- 4456US11332473B2Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitorsNUVATION BIO INC·Filed 2020·Granted May 17, 2022·0 cites·60 claims
- 4556US2023174545A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 4656US2016256440A1Multisubstituted aromatic compounds as inhibitors of thrombinVERSEON CORP·Filed 2016·Application pending·0 cites
- 4755US2023023009A1Heterocyclic compounds and methods of use thereofSPARCBIO LLC·Filed 2021·Application pending·0 cites
- 4855US2023026856A1Heterocyclic compounds and methods of use thereofSPARCBIO LLC·Filed 2021·Application pending·0 cites
- 4955US2016122333A1Multisubstituted aromatic compounds as inhibitors of thrombinVERSEON CORP·Filed 2016·Application pending·0 cites
- 5054US11254670B21,8-naphthyridinone compounds and uses thereofNUVATION BIO INC·Filed 2020·Granted Feb 22, 2022·0 cites·37 claims
Showing the top 50 of 74 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Son Minh Pham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →